Trade receivables increased 668.8%
Trade receivables changed +668.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$468,000→$3.6M4 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →DVLT financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Free-cash-flow proxy changed across a low base
Free-cash-flow proxy changed -951.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a low base.
-$6.8M→-$71.6M4 prior comparisons
Operating cash flow changed across a low base
Operating cash flow changed -946.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a low base.
-$6.8M→-$71.2M4 prior comparisons
Working capital / assets moved 4251 bp higher
Working capital / assets changed +4251 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
-3.58%→38.93%4 prior comparisons
Stock-based compensation increased 391.5%
Stock-based compensation changed +391.5% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$1.2M→$5.7M4 prior comparisons
Operating income decreased 112.3%
Operating income changed -112.3% from the comparable as-filed period.
-$12.5M→-$26.5M3 prior comparisons
Operating margin moved 32423 bp higher
Operating margin changed +32423 basis points from the comparable as-filed period.
-718.10%→-393.87%3 prior comparisons
Revenue increased 287.1%
Revenue changed +287.1% from the comparable as-filed period.
$1.7M→$6.7M3 prior comparisons
Gross margin moved 4083 bp higher
Gross margin changed +4083 basis points from the comparable as-filed period.
2.02%→42.85%3 prior comparisons
Capex / revenue moved 473 bp higher
Capex / revenue changed +473 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
0.00%→4.73%3 prior comparisons
Research & development increased 71.3%
Research & development changed +71.3% from the comparable as-filed period.
$4.2M→$7.2M3 prior comparisons
Cash & equivalents increased 111.5%
Cash & equivalents changed +111.5% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$662,000→$1.4M4 prior comparisons
Shares outstanding increased 872.2%
Shares outstanding changed +872.2% from the comparable as-filed period. The change ranks at the 38th percentile of 8 prior comparable changes.
97,692,374→949,728,6058 prior comparisons
Current liabilities increased 235.9%
Current liabilities changed +235.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$8.1M→$27.3M4 prior comparisons
Total assets increased 129.2%
Total assets changed +129.2% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$120.7M→$276.6M4 prior comparisons
Current ratio changed across a low base
Current ratio changed +958.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a low base.
0.47→4.954 prior comparisons
Inventory / revenue moved 6465 bp lower
Inventory / revenue changed -6465 basis points from the comparable as-filed period.
78.67%→14.02%3 prior comparisons
Cost of revenue increased 125.8%
Cost of revenue changed +125.8% from the comparable as-filed period.
$1.7M→$3.8M3 prior comparisons
Inventory decreased 31.0%
Inventory changed -31.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$1.4M→$942,0004 prior comparisons
Current assets changed across a low base
Current assets changed +3455.3% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a low base.
$3.8M→$135.0M4 prior comparisons
Operating cash-flow margin moved 66820 bp lower
Operating cash-flow margin changed -66820 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
-392.33%→-1060.53%3 prior comparisons
Free-cash-flow margin moved 67293 bp lower
Free-cash-flow margin changed -67293 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
-392.33%→-1065.27%3 prior comparisons
Receivables / revenue moved 2659 bp higher
Receivables / revenue changed +2659 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
26.97%→53.57%3 prior comparisons
SBC / revenue moved 1788 bp higher
SBC / revenue changed +1788 basis points from the comparable as-filed period.
66.34%→84.22%3 prior comparisons
R&D / revenue moved 13575 bp lower
R&D / revenue changed -13575 basis points from the comparable as-filed period.
243.46%→107.71%3 prior comparisons
Gross profit changed across a low base
Gross profit changed +8122.9% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base.
$35,000→$2.9M3 prior comparisons
Working capital changed across a sign change
Working capital changed +2592.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a sign change.
-$4.3M→$107.7M4 prior comparisons
Capital expenditure changed across a zero base
Capital expenditure changed from 0 to 318000 USD in the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a zero base.
$0→$318,0004 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.